Programme

Home »  Archive »  1st Cardionale 2010 »  Programme

Lectures

Scientific program – lectures & invited speakers

FRIDAY 26, November

Time Lecture Speaker
09:00 Opening ceremony Prof. Richard Češka, MD, Rob Koremans, president of ZENTIVA
  QUALITY OF CARDIOVASCULAR RISK MANAGEMENT Chairs: Prof. Renata Cífková, MD (CZ), Prof. Richard Češka, MD (CZ)
09:15 – 9:35 Epidemiology of cardiovascular diseases in CEE region (other countries) Prof. Renata Cífková, MD (CZ)
09:35 – 9:55 Euroaspire I. – III. Prof. David A. Wood, MD (UK)
09:55 – 10:15 Differences in Cardiovascular Mortality Between Western and Eastern Europe Prof. Martin Bobak, MD (UK)
10:15 – 10:30 Discussion  
10:30 – 11:00 Break  
11:00 – 11:20 Perspective from university hospital in large city in Czech Republic Prof. Jindřich Špinar, MD (CZ)
11:20 – 11:40 Perspective from first line and regional hospital in Czech Republic Petr Janský, MD (CZ)
11:40 – 12:00 Difference in cardiovascular treatment penetration in selected countries of Western, Central and Eastern Europe Petr Jelínek, MD (CZ)
12:00 – 12:30 Interactive session – countries experiences Moderate: Prof. Richard Češka, MD (CZ)
12:30 – 13:30 Lunch  
  DYSLIPIDEMIA Chairs: Michal Vráblík, MD (CZ), Prof. Richard Češka, MD (CZ)
13:30 – 14:00 Aggressive Lipid Management Prof. Richard Češka, MD (CZ)
14:00 – 14:30 JUPITER: the greatest but not the only in the galaxy of rosuvastatin data Michal Vrablík, MD (CZ)
14:30 – 15:00 Pharmacoeconomic insight in current dyslipidemia treatment Jana Skoupá, MD (CZ)
15:00 – 15:15 Discussion  
15:15 – 15:45 Break  
  HYPERTENSION Chairs: Prof. Richard Češka, MD (CZ), Prof. Jindřich Špinar, MD (CZ)
15:45 – 16:15 General overview (guidelines) Ass. Prof. Andrzej Tomaszewski, MD (PL)
16:15 – 16:40 Valsartan – affordable standard mainly for HF and post MI patients Prof. Jidřich Špinar, MD (CZ )
16:40 – 17:00 Discussion All

SATURDAY 27, November

Time Lecture Speaker – Chairman
09:00 – 09:20 Lercanidipine – a novel CCB – what is its role in current antihypertensive treatment? Alma Cypiene, MD (LT)
09:20 – 10:00 Future trends in hypertensioin treatment. Prof. Jiří Widimský jr., MD (CZ)
10:00 – 10:15 CORD study Prof. Jindřich Špinar, MD (CZ)
10:15 – 10:45 Break  
  ANTIPLATELET THERAPY  
11:00 – 11:30 Antiplatelet therapy in general overview Prof. Lale Tokgozoglu, MD (TR)
11:30 – 11:45 Antiagregants in ACS Karlis Trusinskis, MD (LV)
11:45 – 12:00 Antiagregants in Stroke Prof. Ovidiu Bajenaru, MD (RO)
12:00 – 12:15 Antiagregants in PAD Ass. Prof. Debora Karetová, MD (CZ)
12:15 – 12:45 Discussion, Closing remarks all
12:45 Lunch  

There is a pending application for EACCME acreditation ( European Accreditation Council for Continuing Medical Education) at the moment.

Working languages

The meeting will be conducted in English.
Simultaneous translation: Turkish, Russian